PMID- 26282490 OWN - NLM STAT- MEDLINE DCOM- 20160315 LR - 20211203 IS - 1872-7786 (Electronic) IS - 0009-2797 (Linking) VI - 240 DP - 2015 Oct 5 TI - Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-1alpha. PG - 48-58 LID - S0009-2797(15)30035-1 [pii] LID - 10.1016/j.cbi.2015.08.006 [doi] AB - The hypoxia-inducible factor-1 (HIF-1) has been known to be correlated to the adaptation and proliferation of tumor cells; therefore HIF-1 has become an important target in the development of anticancer drugs. Dihydrotanshinone I (DHTS) is a phenanthrenequinone compound from Salvia miltiorrhiza Bunge, which has been used in oriental medicine for its antitumor activities. However, the mechanisms by which DHTS inhibits tumor growth are not fully understood. We here demonstrated the effect of DHTS on hypoxia-inducible factor-1 (HIF-1) activation. DHTS dose-dependently decreased the hypoxia-induced accumulation and activation of HIF-1alpha protein. Further analysis revealed that DHTS inhibited HIF-1alpha protein synthesis, without affecting the expression level of HIF-1alpha mRNA or degradation of HIF-1alpha protein. Moreover, the phosphorylation levels of mammalian target of rapamycin (mTOR), extracellular signal-regulated kinase-1/2 (ERK1/2), ribosomal protein S6 kinase (p70S6K), eIF4E binding protein-1 (4E-BP1), and eukaryotic initiation factor 4E (eIF4E) were dose-dependently suppressed by DHTS, but no significant effect on total protein levels was observed. Furthermore, DHTS prevented hypoxia-induced expression of HIF-1 target genes and flow cytometric analysis indicated that DHTS induced G1 phase arrest in HeLa cell. In vivo studies further confirmed the inhibitory effect of DHTS on the expression of HIF-1alpha proteins, leading to a decrease in growth of HeLa cells in a xenograft tumor model. These results show that DHTS inhibited HIF-1alpha protein synthesis by downregulating the mTOR/p70S6K/4E-BP1 and MEK/ERK pathways. These conclusions suggest that DHTS is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity. CI - Copyright (c) 2015 Elsevier Ireland Ltd. All rights reserved. FAU - Li, Jing AU - Li J AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. FAU - Mi, Chunliu AU - Mi C AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. FAU - Ma, Juan AU - Ma J AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. FAU - Wang, Ke Si AU - Wang KS AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. FAU - Lee, Jung Joon AU - Lee JJ AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. FAU - Jin, Xuejun AU - Jin X AD - Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Department of Chemistry, College of Pharmacy, Molecular Medicine Research Center, Yanbian University, Yanji 133002, Jilin Province, China. Electronic address: xjjin@ybu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150814 PL - Ireland TA - Chem Biol Interact JT - Chemico-biological interactions JID - 0227276 RN - 0 (Antineoplastic Agents) RN - 0 (Furans) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Phenanthrenes) RN - 0 (Quinones) RN - 562G9360V6 (dihydrotanshinone I) SB - IM MH - Antineoplastic Agents/pharmacology MH - Cell Proliferation/drug effects MH - Furans MH - Gene Expression Profiling MH - Gene Expression Regulation/*drug effects MH - HeLa Cells MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors/*genetics/metabolism MH - Phenanthrenes/*pharmacology MH - Polymerase Chain Reaction MH - Quinones MH - Signal Transduction/drug effects OTO - NOTNLM OT - Anticancer OT - Dihydrotanshinone I (DHTS) OT - ERK1/2 OT - HIF-1 OT - mTOR EDAT- 2015/08/19 06:00 MHDA- 2016/03/16 06:00 CRDT- 2015/08/19 06:00 PHST- 2015/04/30 00:00 [received] PHST- 2015/07/07 00:00 [revised] PHST- 2015/08/10 00:00 [accepted] PHST- 2015/08/19 06:00 [entrez] PHST- 2015/08/19 06:00 [pubmed] PHST- 2016/03/16 06:00 [medline] AID - S0009-2797(15)30035-1 [pii] AID - 10.1016/j.cbi.2015.08.006 [doi] PST - ppublish SO - Chem Biol Interact. 2015 Oct 5;240:48-58. doi: 10.1016/j.cbi.2015.08.006. Epub 2015 Aug 14.